Agents for treating neurodegenerative disorders

1 22 2 223 Compounds and methods of using these compounds to treat neurodegenerative diseases, especially Alzheimer's disease, are provided. The compounds that are provided for the treatment of neurodegenerative diseases can be represented by a general formula (I): wherein Ris Me, Et or PhCH; R...

Full description

Saved in:
Bibliographic Details
Main Authors Zefirov, Nikolai S, Afanasiev, Andrei Z, Afanasieva, Svetlana V, Bachurin, Sergei O, Tkachenko, Sergei E, Grigoriev, Vladmir V, Jurovskaya, Marina A, Chetverikov, Valery P, Bukatina, Elizaveta E, Grigorieva, Irina V
Format Patent
LanguageEnglish
Published 04.07.2006
Online AccessGet full text

Cover

More Information
Summary:1 22 2 223 Compounds and methods of using these compounds to treat neurodegenerative diseases, especially Alzheimer's disease, are provided. The compounds that are provided for the treatment of neurodegenerative diseases can be represented by a general formula (I): wherein Ris Me, Et or PhCH; Ris H, PhCHor 6-Me-3-Py-(CH); and Ris H, Me or Br. The solid line accompanied by the dotted line i.e. represents a single or double bond and salts thereof with pharmacologically acceptable acids and quaternary derivatives.